A dual-chamber, thick-walled cardiac phantom for use in cardiac motion and deformation imaging by ultrasound.

Determination of the mechanical properties of the myocardium is crucial for cardiac diagnosis. Cardiac strain and strain rate imaging may enable such quantification. To further develop these methodologies, an experimental setup allowing the recording of ultrasonic deformation data in a reproducible manner is necessary. Such setup with biventricular polyvinyl alcohol heart phantoms has been built. To test this setup, segmental longitudinal, radial and circumferential displacement, velocity, strain and strain rate in the phantoms were measured using a clinical ultrasound scanner and commercially available deformation imaging algorithms (based on both tissue velocity imaging and speckle tracking). The model deformation was close to that observed in the human left ventricular wall and was highly reproducible (e.g., the average peak longitudinal strain for the mid- and apical phantom segments equals -15.32 +/- 0.53% and -19 +/- 6% for the ventricle wall). The experimental setup is a valuable source of data for the development of algorithms for deformation estimation.

Rapid detection of autoantibodies to dsDNA with the particle gel immunoassay (ID-PaGIA).

OBJECTIVE: To describe a new particle agglutination test for the detection of autoantibodies to double stranded DNA (dsDNA). PATIENTS AND METHODS: Serum samples were collected from 40 unselected healthy blood donors and 200 patients with systemic lupus erythematosus (SLE) or a positive antinuclear antibody screen, or both. The samples were tested in the presence of red high density polystyrene particles coated with purified human dsDNA using the gel technique (Micro Typing System, ID-PaGIA, particle gel immunoassay). The results were compared with those obtained by the two standard anti-dsDNA antibody detection methods, Crithidia luciliae immunofluorescence test (CLIF) and enzyme linked immunosorbent assay (ELISA). RESULTS: The three anti-dsDNA assays exhibited an overall agreement of 87% and significant correlation with each other (p<0.0001). In the SLE group (n=71), 45 patients (63%) were found to be positive by ID-PaGIA compared with only 11/129 (9%) patients in the non-SLE group. Thus the ID-PaGIA had a sensitivity of 63%, and a specificity of 92% for SLE. In comparison, the standard detection methods showed sensitivities of 62% (CLIF) and 70% (ELISA) and specificities of 99% (CLIF) and 84% (ELISA) for SLE. Anti-dsDNA reactivity in the agglutination assay correlated closely with the quantities of antibody obtained by CLIF (r=0.81, p<0.0001) and ELISA (r=0.73, p<0.0001). CONCLUSIONS: The new particle gel agglutination test is a sensitive and specific immunoassay. It is a simple test procedure that might be well suited as a rapid screening method.